GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Stem Cells Spin SA (WAR:SCS) » Definitions » Gross-Profit-to-Asset %

Stem Cells Spin (WAR:SCS) Gross-Profit-to-Asset % : 1.56% (As of Dec. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Stem Cells Spin Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Stem Cells Spin's annualized Gross Profit for the quarter that ended in Dec. 2024 was zł0.19 Mil. Stem Cells Spin's average Total Assets over the quarter that ended in Dec. 2024 was zł12.31 Mil. Therefore, Stem Cells Spin's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2024 was 1.56%.


Stem Cells Spin Gross-Profit-to-Asset % Historical Data

The historical data trend for Stem Cells Spin's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stem Cells Spin Gross-Profit-to-Asset % Chart

Stem Cells Spin Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.66 3.03 1.43 2.64 0.37

Stem Cells Spin Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.98 - -0.03 -0.03 1.56

Competitive Comparison of Stem Cells Spin's Gross-Profit-to-Asset %

For the Biotechnology subindustry, Stem Cells Spin's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stem Cells Spin's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Stem Cells Spin's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Stem Cells Spin's Gross-Profit-to-Asset % falls into.


;
;

Stem Cells Spin Gross-Profit-to-Asset % Calculation

Stem Cells Spin's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2024 )/( (Total Assets (A: Dec. 2023 )+Total Assets (A: Dec. 2024 ))/ count )
=0.047/( (13.609+11.981)/ 2 )
=0.047/12.795
=0.37 %

Stem Cells Spin's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Dec. 2024 )/( (Total Assets (Q: Sep. 2024 )+Total Assets (Q: Dec. 2024 ))/ count )
=0.192/( (12.648+11.981)/ 2 )
=0.192/12.3145
=1.56 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Dec. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Stem Cells Spin Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Stem Cells Spin's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Stem Cells Spin Business Description

Traded in Other Exchanges
N/A
Address
Ulica Konopnickiej 15 b, Wroclaw, POL, 51-141
Stem Cells Spin SA is a biotechnology company. The company is engaged in the development, production, marketing and sale of natural regenerative products for the dermocosmetic and veterinary care markets, as well as applications for the human and veterinary medical industry. Its products include NHAC Biocervin MIC-1, Revitacell, PRS MIC-1 and Velvetyna.